Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #105568 on Biotech Values
dewophile
10/04/10 11:59 AM
#105569 RE: mouton29 #105568
You mean, by potentially slowing down or derailing generic Copaxone, they might encourage NVS to exercise the option?
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads